Provided by Tiger Trade Technology Pte. Ltd.

Werewolf Therapeutics, Inc.

1.07
-0.0100-0.93%
Volume:470.71K
Turnover:531.54K
Market Cap:51.94M
PE:-0.66
High:1.20
Open:1.11
Low:1.06
Close:1.08
52wk High:2.38
52wk Low:0.5950
Shares:48.54M
Float Shares:35.00M
Volume Ratio:1.10
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6177
EPS(LYR):-1.6273
ROE:-122.43%
ROA:-40.75%
PB:1.75
PE(LYR):-0.66

Loading ...

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
10 hours ago

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 13

Director Luke Evnin Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 10

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05

Former 10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 05

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02

MPM BioVentures 2014 L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Dec 02

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 26

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 26

Werewolf Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
Nov 19

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18

10% Owner Ansbert Gadicke Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 18

Director Luke Evnin Reports Sale of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 13

MPM BioVentures 2014, L.P. Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 13

10% Owner Ansbert Gadicke Reports Sale of Werewolf Therapeutics Common Shares

Reuters
·
Nov 13

Werewolf Therapeutics Unveils Tumor-Selective INDUKINE Data at SITC 2025

Reuters
·
Nov 07

Director Luke Evnin Reports Disposal of Werewolf Therapeutics Inc. Common Shares

Reuters
·
Nov 07